GenMont Biotech Incorporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 325.191 million compared to TWD 346.244 million a year ago. Operating income was TWD 71.014 million compared to TWD 77.623 million a year ago. Net income was TWD 60.884 million compared to TWD 57.451 million a year ago. Basic earnings per share was TWD 0.69 compared to TWD 0.65 a year ago. Diluted earnings per share was TWD 0.69 compared to TWD 0.64 a year ago.